Bibliography
- WALSH C: Where will new antibiotics come from? Nat. Rev Microbial (2003) 1(1):65–70.
- SPELLBERG B, POWERS JH, BRASS EP, MILLER LG, EDWARDS JE Jr: Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. (2004) 38(9):1279–1286.
- PROJAN SJ: Why is big Pharma getting out of antibacterial drug discovery? Curr. Opia Microbial (2003) 6(5): 427–430.
- SHLAES DM: The abandonment of antibacterials: why and wherefore? Curr. Opin. Pharmacol (2003) 3(5):470–473.
- SELLERS LJ: Big Pharma bails on anti-infectives research. Pharmaceutical Executive (2003) 22.
- PROJAN SJ, SHLAES DM: Antibacterial drug discovery: is it all downhill from here? Clia Microbial. Infect. (2004) 10\(Suppl. 4):18–22.
- DIMASI JA, HANSEN RW, GRABOWSKI HG: The price of innovation: new estimates of drug development costs. J. Health Econ. (2003) 22(2):151–185.
Websites
- http://www.idsociety.org IDSA White Paper. Bad Bugs, No Drugs.. .A Public Health Crises Brews (2004).